December 31, 2015: Researchers First Used CRISPR to Treat a Genetic Disease in Mice

2017-12-31|

December 31, 2015: Researchers First Used CRISPR to Treat a Genetic Disease in Mice

by GeneOnline

Share To

Researchers at the Duke University used CRISPR technology to treat Duchenne Muscular Dystrophy (DMD), and published the report on December 31, 2015 on Science journal. DMD is a genetic disease that can also occur in humans. This was the first case in which CRISPR technology is used to treat inherited diseases in adult mammals and was of great importance to the development of human gene therapy.

Reference
http://www.sciencemag.org/news/2015/12/crispr-helps-heal-mice-muscular-dystrophy

Author

GeneOnline

R&D

Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor

2024-05-08

Region

PrecisionMed Exhibition & Summit returns to the UAE for its third edition, featuring world-class teaching, unparalleled industry support, and innovation showcases

2024-05-06

R&D

Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments

2024-04-16

LATEST

2024 Nobel Prize in Medicine: Uncovering the Secrets of microRNA in Gene Regulation

2024-10-08

Sciwind Biosciences Announces Oral Presentation on Oral GLP-2 Research Progress at the 32nd United European Gastroenterology Week (UEG Week 2024)

2024-10-07

Bio Japan 2024 and Medical Japan 2024 Unleashing Innovation in Biopharmaceuticals and Healthcare Technologies

2024-10-07

Starboard Value Takes $1 Billion Stake in Pfizer, Eyes Major Overhaul

2024-10-07

Generative AI Makes its Debut in Smart Healthcare with NVIDIA Experts at the Helm

2024-10-04

How TCELS is Moving Thailand’s Biotech Industries From Local to Global

2024-10-04

Lilly Invests $4.5B in Indiana Facility for In-House Clinical Manufacturing

2024-10-03

EVENT

2024-10-09

Medical Japan 2024 Tokyo

Tokyo, Japan

2024-10-10

BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2024

Tokyo, Japan

2024-10-15

BIO Investor Forum 2024

San Francisco, U.S.A.

2024-10-28

BioFuture 2024

New York, U.S.A.

2024-10-30

AusBiotech 2024

Melbourne, Australia

2024-11-04

BIO-Europe 2024

Stockholm, Sweden

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

GENE ONLINE|News &
Opinion
Blog